http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
Boston Scientific (BSX) to Acquire VENITI, Inc.
-
Boston Scientific Announces Agreement to Acquire VENITI, Inc.
-
Boston Scientific Closes Acquisition of Claret Medical, Inc., Announces Positive Reimbursement Decision
-
Boston Scientific to Participate in 38th Annual Canaccord Genuity Growth Conference
-
Boston Scientific Announces Results For Second Quarter 2018
-
Boston Scientific Corporation Recommends Stockholders Reject 'Mini-Tender' Offer by TRC Capital Corporation
-
Boston Scientific (BSX) to Acquire Claret Medical for up to $270M
-
Boston Scientific Announces Agreement to Acquire Claret Medical, Inc.
-
Boston Scientific (BSX) to Acquire Remaining Stake in Cryterion Medical for $202 Million
-
Boston Scientific to Acquire Cryterion Medical, Inc.
-
Boston Scientific Announces Conference Call Discussing Second Quarter 2018 Financial Results
-
Boston Scientific Announces Scheduled Presentations At Digestive Disease Week 2018
-
Boston Scientific Announces Schedule of Presentations at EuroPCR 2018
-
Boston Scientific Announces Schedule of Presentations at EuroPCR 2018
-
Boston Scientific To Participate In 34th Annual Strategic decisions Conference
-
Boston Scientific Announces Real-World Data Demonstrating Success Of SMART Pass On The S-ICD System
-
Boston Scientific To Participate In Bank of America Merrill Lynch 2018 Health Care Conference
-
Boston Scientific Closes NxThera Acquisition
-
Boston Scientific Announces Results For First Quarter 2018
-
Boston Scientific (BSX) Reports Positive Late-Breaking Data from INTREPID Study
-
Boston Scientific Announces Positive Late-Breaking Data From The INTREPID Study
-
Boston Scientific (BSX) Prevails In European Patent Dispute With Edwards Lifesciences (EW)
-
Boston Scientific Prevails In European Patent Dispute With Edwards Lifesciences
-
Boston Scientific (BSX) Acquires nVision Medical Corporation
-
Boston Scientific Announces Acquisition Of nVision Medical Corporation
-
Boston Scientific (BSX) Buys Securus Medical Group for $40 Million Up-Front and $10 Million Contingent
-
Boston Scientific Announces Acquisition of Securus Medical Group, Inc.
-
Boston Scientific Prevails In U.K. Edwards Lifesciences Litigation
-
Boston Scientific Announces Conference Call Discussing First Quarter 2018 Financial Results
-
Boston Scientific (BSX) to Acquire NxThera for $306M in Cash Plus $100M in Milestones
-
Boston Scientific Announces Agreement To Acquire NxThera
-
Boston Scientific (BSX) Says Late-breaking Clinical Trial Data Further Demonstrate Safety and Effectiveness of RHYTHMIA Mapping System
-
Late-breaking Clinical Trial Data Further Demonstrate Safety and Effectiveness of the RHYTHMIA™ Mapping System
-
Boston Scientific to Participate in 17th Annual Needham Healthcare Conference
-
Boston Scientific Announces Scheduled Presentations at EHRA 2018 Congress
-
Boston Scientific To Participate In Barclays Global Healthcare Conference
-
Boston Scientific (BSX) Reports Acquisition of EMcision Ltd.
-
Boston Scientific Announces Acquisition of EMcision, Limited
-
Boston Scientific Announces Results for Fourth Quarter and Full Year 2017
-
Boston Scientific to Participate in LEERINK Partners 7th Annual Global Healthcare Conference
-
Boston Scientific (BSX) Reports Investment, Acquisition Option Agreement with Millipede
-
Boston Scientific Announces Investment and Acquisition Option Agreement with Millipede, Inc.
-
Boston Scientific Announces Updated Time For Webcast Conference Call Discussing Fourth Quarter 2017 Financial Results
-
Boston Scientific (BSX) Reports Positive Results from WHISPER Spinal Cord Stimulation Study
-
Boston Scientific Announces Positive Results from WHISPER Spinal Cord Stimulation Study
-
Boston Scientific (BSX) Reports FDA Approval for Spectra WaveWriter Spinal Cord Stimulator
-
Boston Scientific Receives U.S. FDA Approval for Spectra WaveWriter™ Spinal Cord Stimulator System
-
Boston Scientific (BSX) Prelim. Q4 Sales Top Views
-
Boston Scientific Announces Preliminary Unaudited Sales For The Fourth Quarter And Full Year Ended December 31, 2017
-
Boston Scientific to Webcast Conference Call Discussing Fourth Quarter 2017 Financial Results

